N. DT, C. RB, N. KK. Mortality and survival benefits in people living with human immunodeficiency virus initiated newly with Antiretroviral therapy irrespective of CD4 count. Int J Adv Med [Internet]. 2020 Jan. 23 [cited 2025 Nov. 17];7(2):272-5. Available from: https://www.ijmedicine.com/index.php/ijam/article/view/2087